These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23808957)

  • 1. Comparative genome analysis of ciprofloxacin-resistant Pseudomonas aeruginosa reveals genes within newly identified high variability regions associated with drug resistance development.
    Su HC; Khatun J; Kanavy DM; Giddings MC
    Microb Drug Resist; 2013 Dec; 19(6):428-36. PubMed ID: 23808957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of ciprofloxacin resistance in Pseudomonas aeruginosa: new approaches to an old problem.
    Rehman A; Patrick WM; Lamont IL
    J Med Microbiol; 2019 Jan; 68(1):1-10. PubMed ID: 30605076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudomonas aeruginosa variants obtained from veterinary clinical samples reveal a role for cyclic di-GMP in biofilm formation and colony morphology.
    Brock MT; Fedderly GC; Borlee GI; Russell MM; Filipowska LK; Hyatt DR; Ferris RA; Borlee BR
    Microbiology (Reading); 2017 Nov; 163(11):1613-1625. PubMed ID: 29034850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ciprofloxacin concentration on the frequency and nature of resistant mutants selected from Pseudomonas aeruginosa mutS and mutT hypermutators.
    Morero NR; Monti MR; Argaraña CE
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3668-76. PubMed ID: 21646492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. gyrA and parC mutations in quinolone-resistant clinical isolates of Pseudomonas aeruginosa from Nini Hospital in north Lebanon.
    Salma R; Dabboussi F; Kassaa I; Khudary R; Hamze M
    J Infect Chemother; 2013 Feb; 19(1):77-81. PubMed ID: 22821356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sublethal ciprofloxacin treatment leads to rapid development of high-level ciprofloxacin resistance during long-term experimental evolution of Pseudomonas aeruginosa.
    Jørgensen KM; Wassermann T; Jensen PØ; Hengzuang W; Molin S; Høiby N; Ciofu O
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4215-21. PubMed ID: 23774442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GyrA mutations in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa in a Silesian Hospital in Poland.
    Wydmuch Z; Skowronek-Ciołek O; Cholewa K; Mazurek U; Pacha J; Kepa M; Idzik D; Wojtyczka RD
    Pol J Microbiol; 2005; 54(3):201-6. PubMed ID: 16450835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of gyrA and parC mutations in fluoroquinolones-resistant Pseudomonas aeruginosa isolates from Iran.
    Nouri R; Ahangarzadeh Rezaee M; Hasani A; Aghazadeh M; Asgharzadeh M
    Braz J Microbiol; 2016; 47(4):925-930. PubMed ID: 27522930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and physiological characterization of ciprofloxacin resistance in Pseudomonas aeruginosa PAO.
    Robillard NJ; Scarpa AL
    Antimicrob Agents Chemother; 1988 Apr; 32(4):535-9. PubMed ID: 2837141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant prevention concentration for ciprofloxacin and levofloxacin with Pseudomonas aeruginosa.
    Hansen GT; Zhao X; Drlica K; Blondeau JM
    Int J Antimicrob Agents; 2006 Feb; 27(2):120-4. PubMed ID: 16426820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in the GyrA and GyrB subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa.
    Lee JK; Lee YS; Park YK; Kim BS
    Int J Antimicrob Agents; 2005 Apr; 25(4):290-5. PubMed ID: 15784307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of Pseudomonas aeruginosa Antimicrobial Resistance and Fitness under Low and High Mutation Rates.
    Cabot G; Zamorano L; Moyà B; Juan C; Navas A; Blázquez J; Oliver A
    Antimicrob Agents Chemother; 2016 Jan; 60(3):1767-78. PubMed ID: 26729493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Susceptibility of 570 Pseudomonas aeruginosa strains to 11 antimicrobial agents and the mechanism of its resistance to fluoroquinolones].
    Lei YC; Wang HB; Sun ZY; Shen ZY
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):403-7. PubMed ID: 12820918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa develops Ciprofloxacin resistance from low to high level with distinctive proteome changes.
    Peng J; Cao J; Ng FM; Hill J
    J Proteomics; 2017 Jan; 152():75-87. PubMed ID: 27771372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial Resistance and Whole-Genome Characterisation of High-Level Ciprofloxacin-Resistant
    Wołkowicz T; Zacharczuk K; Gierczyński R; Nowakowska M; Piekarska K
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutator genes giving rise to decreased antibiotic susceptibility in Pseudomonas aeruginosa.
    Wiegand I; Marr AK; Breidenstein EB; Schurek KN; Taylor P; Hancock RE
    Antimicrob Agents Chemother; 2008 Oct; 52(10):3810-3. PubMed ID: 18663021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ciprofloxacin binding to GyrA causes global changes in the proteome of Pseudomonas aeruginosa.
    Jedrey H; Lilley KS; Welch M
    FEMS Microbiol Lett; 2018 Jul; 365(13):. PubMed ID: 29846552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of in vitro resistance to fluoroquinolones in Pseudomonas aeruginosa.
    Zhao L; Wang S; Li X; He X; Jian L
    Antimicrob Resist Infect Control; 2020 Aug; 9(1):124. PubMed ID: 32758289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Environmental mutagens may be implicated in the emergence of drug-resistant microorganisms.
    Miyahara E; Nishie M; Takumi S; Miyanohara H; Nishi J; Yoshiie K; Oda H; Takeuchi M; Komatsu M; Aoyama K; Horiuchi M; Takeuchi T
    FEMS Microbiol Lett; 2011 Apr; 317(2):109-16. PubMed ID: 21241358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of ParE mutation and efflux to ciprofloxacin resistance in Pseudomonas aeruginosa clinical isolates.
    Réjiba S; Aubry A; Petitfrère S; Jarlier V; Cambau E
    J Chemother; 2008 Dec; 20(6):749-52. PubMed ID: 19129075
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.